Name: Clinical Development of Orphan and Pediatric Drugs, Along with Regenerative Medicine Products in Japan
Start: 2025-06-18T13:45:00-0400
End: 2025-06-18T14:45:00-0400

Wednesday June 18, 2025 1:45pm - 2:45pm EDT

TBD

Component Type: Session
Level: Intermediate

Japan's regulatory authorities have enacted various measures to strengthen drug R&D and accelerate clinical development, particularly for regenerative medicine, pediatric, and orphan drugs, offering great prospects for biopharma/ biotech companies.

Learning Objectives

Examine PMDA's efforts to address Japan's drug lag and promote an accelerated clinical development environment; Evaluate the trial landscape and analyze the challenges in developing Regenerative Medicine, Orphan, and Pediatric drugs in Japan; Develop strategies for Japan to engage in multi-regional trials, considering the unique aspects of conducting clinical studies in the country.

Chair

Edward C. Ian, MBA

Speakers

Edward Ian

Senior Executive Officer, Mediscience Planning Inc., Japan

Edward Ian began his career as a lab. scientist and expanded his work into clinical development. His extensive experience with multinational companies in APAC and the US has made him a seasoned executive with expertise across a wide range of areas within the clinical research and... Read More →

Wednesday June 18, 2025 1:45pm - 2:45pm EDT
TBD Walter E. Washington Convention Center 801 Allen Y. Lew Place, NW Washington, DC 20001-3614 USA

02: ClinTrials-Ops, Session

Format Session
Level Intermediate
Level Intermediate
format csv
Tags Session

DIA 2025 Global Annual Meeting

Edward Ian

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!